Advent Life Sciences is one of the leading trans-Atlantic venture investors focused on building innovative Life Sciences businesses in the UK, Europe and the USA. We are a highly experienced team with a long-standing track record of entrepreneurial and investment success through turning break-through science into approved medicines or medical products. We start and invest in early and mid-stage companies with a first-in-class or best-in-class approach. Our investments are focussed in new drug discovery - small molecules, biologics and new modalities - med tech, enabling technologies and vaccines. As entrepreneurs and experienced, pragmatic investors, we bring the intellectual capital of our well connected team to support each investment. We work in close alignment with our management teams, and partner with them to realise their vision - achieving superior financial returns by bringing innovation to patients. The companies in which we have invested since the year 2000 have discovered and developed, fourteen approved medicines and products - to the benefit of patients, physicians and our investors.
| Website | http://www.adventls.com |
| Revenue | $5.1 million |
| Employees | 24 (11 on RocketReach) |
| Founded | 2005 |
| Phone | +44 20 3877 5657 |
| Technologies |
JavaScript
,
Google Analytics
,
jQuery
+7 more
(view full list)
|
| Industry | Venture Capital, Venture Capital and Private Equity Principals, Finance, Financial Services, Life Sciences, Lending and Investments |
| Web Rank | 7 Million |
| Keywords | Life Sciences Venture Capital, Biotech Venture Capital, Pharmaceutical Funding, Healthcare Venture Capital, Drug Development Funding, Life Science Startups, Pharmaceutical Startups |
| Competitors | Baird Capital, New Enterprise Associates (NEA), OrbiMed, MPM BioImpact, Canaan, ARCH Venture Partners, Abingworth, Sofinnova Investments, Domain Associates, Life Sciences Partners (LSP) +48 more (view full list) |
Looking for a particular Advent Life Sciences employee's phone or email?
The Advent Life Sciences annual revenue was $5.1 million in 2026.
Shahzad Malik is the General Partner of Advent Life Sciences.
11 people are employed at Advent Life Sciences.